The evolution of the CTO-PCI landscape in Belgium and Luxembourg: a four-year appraisal.


Journal

Acta cardiologica
ISSN: 1784-973X
Titre abrégé: Acta Cardiol
Pays: England
ID NLM: 0370570

Informations de publication

Date de publication:
Dec 2021
Historique:
pubmed: 7 8 2020
medline: 21 12 2021
entrez: 7 8 2020
Statut: ppublish

Résumé

To chart the evolution of the CTO-PCI landscape in Belgium and Luxembourg, the Belgian Working Group on Chronic Total Occlusions (BWGCTO) was established in 2016. Between May 2016 and December 2019, patients undergoing a CTO-PCI treatment were prospectively and consecutively enrolled. Twenty-one centres in Belgium and one in Luxembourg participated. Individual operators had mixed levels of expertise in treating CTO lesions. Demographic, angiographic, procedural parameters and incidence of major adverse cardiac and cerebrovascular events (MACCE) were systematically registered. Over a four-year enrolment period, 1832 procedures were performed in 1733 patients achieving technical success in 1474 cases (80%), with an in-hospital MACCE rate of 2.3%. Fifty-nine (3%) cases were re-attempt procedures of which 41 (69%) were successful. High-volume centres treated more complex lesions (mean J-CTO score: 2.15 ± 1.21) as compared to intermediate (mean J-CTO score: 1.72 ± 1.23; With variable experience levels, operators treated CTOs with high success and relatively few complications. Although AWE remains the most used technique, it is paramount for operators to be skilled in all contemporary techniques in order to be successful in more complex CTOs.

Sections du résumé

BACKGROUND BACKGROUND
To chart the evolution of the CTO-PCI landscape in Belgium and Luxembourg, the Belgian Working Group on Chronic Total Occlusions (BWGCTO) was established in 2016.
METHODS METHODS
Between May 2016 and December 2019, patients undergoing a CTO-PCI treatment were prospectively and consecutively enrolled. Twenty-one centres in Belgium and one in Luxembourg participated. Individual operators had mixed levels of expertise in treating CTO lesions. Demographic, angiographic, procedural parameters and incidence of major adverse cardiac and cerebrovascular events (MACCE) were systematically registered.
RESULTS RESULTS
Over a four-year enrolment period, 1832 procedures were performed in 1733 patients achieving technical success in 1474 cases (80%), with an in-hospital MACCE rate of 2.3%. Fifty-nine (3%) cases were re-attempt procedures of which 41 (69%) were successful. High-volume centres treated more complex lesions (mean J-CTO score: 2.15 ± 1.21) as compared to intermediate (mean J-CTO score: 1.72 ± 1.23;
CONCLUSION CONCLUSIONS
With variable experience levels, operators treated CTOs with high success and relatively few complications. Although AWE remains the most used technique, it is paramount for operators to be skilled in all contemporary techniques in order to be successful in more complex CTOs.

Identifiants

pubmed: 32755286
doi: 10.1080/00015385.2020.1801197
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1043-1051

Auteurs

Ward Eertmans (W)

Department of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.
Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.

Peter Kayaert (P)

Department of Cardiology, UZ Gent, Gent, Belgium.

Johan Bennett (J)

Department of Cardiovascular Medicine, UZ Leuven, Leuven, Belgium.

Claudiu Ungureanu (C)

Department of Cardiology, Hôpital de Jolimont, La Louvière, Belgium.

Yoann Bataille (Y)

Department of Cardiology, CHR de la Citadelle, Liège, Belgium.
Department of Cardiology, Jessa Ziekenhuis, Hasselt, Belgium.

Georges Saad (G)

Department of Cardiology, CHR de la Citadelle, Liège, Belgium.

Steven Haine (S)

Department of Cardiology, Antwerp University Hospital, Edegem, Belgium.
Department of Cardiovascular Diseases, University of Antwerp, Wilrijk, Belgium.

Patrick Coussement (P)

Department of Cardiology, AZ Sint-Jan Brugge, Brugge, Belgium.

Bruno Pereira (B)

Department of Cardiology, INCCI Haerz Center, Luxembourg, Luxembourg.

Pierfrancesco Agostoni (P)

HartCentrum, Ziekenhuis Netwerk Antwerpen (ZNA), Middelheim Hospital, Antwerp, Belgium.

Luc Janssens (L)

Department of Cardiology, Imelda Ziekenhuis, Bonheiden, Belgium.

Bert Vandeloo (B)

Department of Cardiology, Centrum voor Hart- en Vaatziekten, UZ Brussel, Jette, Belgium.

Patrick Maréchal (P)

Department of Cardiology, CHU Liège, Liège, Belgium.

Kristoff Cornelis (K)

Department of Cardiology, AZ Maria Middelares, Gent, Belgium.

Quentin de Hemptinne (Q)

Department of Cardiology, CHU Saint-Pierre Université Libre de Bruxelles, Brussel, Belgium.

Adel Aminian (A)

Department of Cardiology, CHU Charleroi, Charleroi, Belgium.

Francis Stammen (F)

Department of Cardiology, AZ Delta, Roeselare, Belgium.

Stéphane Carlier (S)

Department of Cardiology, CHU Ambroise Paré, Mons, Belgium.

Patrick Timmermans (P)

Department of Cardiology, Clinique Saint-Luc Bouge, Namur, Belgium.

Steven Vercauteren (S)

Department of Cardiology, Kliniek Sint-Jan, Brussel, Belgium.

Jeroen Sonck (J)

Department of Cardiology, Centrum voor Hart- en Vaatziekten, UZ Brussel, Jette, Belgium.
Department of Cardiology, Onze Lieve Vrouw Ziekenhuis, Aalst, Belgium.

Frédéric De Vroey (F)

Department of Cardiology, Grand Hôpital de Charleroi, Charleroi, Belgium.

Benny Drieghe (B)

Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.

Keir McCutcheon (K)

Department of Cardiology, UZ Gent, Gent, Belgium.

Benjamin Scott (B)

HartCentrum, Ziekenhuis Netwerk Antwerpen (ZNA), Middelheim Hospital, Antwerp, Belgium.

Laurent Davin (L)

Department of Cardiology, CHU Liège, Liège, Belgium.

Chadi Gafari (C)

Department of Cardiology, CHU Ambroise Paré, Mons, Belgium.

Jo Dens (J)

Department of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.
Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH